Skip to Main Content

Author Details

Daisuke Kawauchi
University of California-San Diego
2003
67
25
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36865329Cooperativity between H3.3K27M and PDGFRA poses multiple therapeutic vulnerabilities in human iPSC-derived diffuse midline glioma avatars.bioRxiv2023
37534529Consulting a neurosurgeon upon initial medical assessment reduces the time to the first surgery and potentially contributes to improved prognosis for glioblastoma patients.Jpn J Clin Oncol2023
37461511Glioblastoma Mesenchymal Transition and Invasion are Dependent on a NF-κB/BRD2 Chromatin Complex.bioRxiv2023
37050422Ligand Installation to Polymeric Micelles for Pediatric Brain Tumor Targeting.Polymers (Basel)2023
36609238Clinical characteristics and prognosis of Glioblastoma patients with infratentorial recurrence.BMC Neurol2023
36460775Caspase-8 as a novel mediator linking Src kinase signaling to enhanced glioblastoma malignancy.Cell Death Differ2023
34839570Eribulin prolongs survival in an orthotopic xenograft mouse model of malignant meningioma.Cancer Sci2022
35798383Primary cilia control translation and the cell cycle in medulloblastoma.Genes Dev2022
35505351Assessment of therapeutic outcome and role of reirradiation in patients with radiation-induced glioma.Radiat Oncol2022
35397757MGMT gene promoter methylation by pyrosequencing method correlates volumetric response and neurological status in IDH wild-type glioblastomas.J Neurooncol2022
35573667Sonic Hedgehog Signaling in Cerebellar Development and Cancer.Front Cell Dev Biol2022
35626060Clinical Application of Comprehensive Genomic Profiling Tests for Diffuse Gliomas.Cancers (Basel)2022
36644632Editorial: Molecular characteristics and personalized treatment for pediatric brain tumors.Front Oncol2022
35951724Early Diagnosis and Surgical Intervention Within 3 Weeks From Symptom Onset Are Associated With Prolonged Survival of Patients With Glioblastoma.Neurosurgery2022
36291588Volumetric Analysis of Glioblastoma for Determining Which CpG Sites Should Be Tested by Pyrosequencing to Predict Temozolomide Efficacy.Biomolecules2022
34985720The clinical characteristics and outcomes of incidentally discovered glioblastoma.J Neurooncol2022
34782365T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas.Clin Cancer Res2022
34050694Epigenetic regulation in medulloblastoma pathogenesis revealed by genetically engineered mouse models.Cancer Sci2021
33879448Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion-Positive Supratentorial Ependymomas.Cancer Discov2021
33741710ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma.Cancer Discov2021
33741711<i>ZFTA</i> Translocations Constitute Ependymoma Chromatin Remodeling and Transcription Factors.Cancer Discov2021
33545065H3.3-K27M drives neural stem cell-specific gliomagenesis in a human iPSC-derived model.Cancer Cell2021
33762301Notch Signaling between Cerebellar Granule Cell Progenitors.eNeuro2021
33728771The ALK inhibitors, alectinib and ceritinib, induce ALK-independent and STAT3-dependent glioblastoma cell death.Cancer Sci2021
33638258Effect of feeding Bacillus subtilis on rumen fermentation, blood metabolites, nutrient digestibility, and energy and nitrogen balances in non-lactating crossbred cows.Anim Sci J2021
34536314Lomustine and nimustine exert efficient antitumor effects against glioblastoma models with acquired temozolomide resistance.Cancer Sci2021
32675324Comparison of tumor-associated YAP1 fusions identifies a recurrent set of functions critical for oncogenesis.Genes Dev2020
33291680Enhanced Malignant Phenotypes of Glioblastoma Cells Surviving NPe6-Mediated Photodynamic Therapy are Regulated via ERK1/2 Activation.Cancers (Basel)2020
30565028Eighty percent survival rate at 15 years for 1p/19q co-deleted oligodendroglioma treated with upfront chemotherapy irrespective of tumor grade.J Neurooncol2019
31414211MYCN amplification drives an aggressive form of spinal ependymoma.Acta Neuropathol2019
31285176Unilateral Occipital Transtentorial Approach with Multimodal Assistance for Resection of Large Supracerebellar Hemangioblastomas: Preliminary Experience of 2 Cases.World Neurosurg2019
31477715YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis.Nat Commun2019
30954745Mechanism of Corpus Callosum Infarction Associated with Acute Hydrocephalus: Clinical, Surgical, and Radiological Evaluations for Pathophysiology.World Neurosurg2019
28536069CRISPR-engineered genome editing for the next generation neurological disease modeling.Prog Neuropsychopharmacol Biol Psychiatry2018
29939173CRISPR-mediated Loss of Function Analysis in Cerebellar Granule Cells Using In Utero Electroporation-based Gene Transfer.J Vis Exp2018
30205043Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling.Cancer Cell2018
27273122Applications of the CRISPR/Cas9 system in murine cancer modeling.Brief Funct Genomics2017
28317875Chd7 is indispensable for mammalian brain development through activation of a neuronal differentiation programme.Nat Commun2017
28669652Severe Vasospasm of the Middle Cerebral Artery after Mechanical Thrombectomy Due to Infective Endocarditis: An Autopsy Case.J Stroke Cerebrovasc Dis2017
28504719Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cells.Oncogene2017
26814967Active medulloblastoma enhancers reveal subgroup-specific cellular origins.Nature2016
27625374FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastoma.EMBO J2016
26766587The Interaction of Myc with Miz1 Defines Medulloblastoma Subgroup Identity.Cancer Cell2016
25531316Cross-species epigenetics identifies a critical role for VAV1 in SHH subgroup medulloblastoma maintenance.Oncogene2015
26251819Life-Threatening Intracranial Hypotension after Skull Base Surgery with Lumbar Drainage.J Neurol Surg Rep2015
26365184TNF Counterbalances the Emergence of M2 Tumor Macrophages.Cell Rep2015
26203775"CRISPR" validation of recessive brain cancer genes in vivo.Oncotarget2015
26067104Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling.Nat Commun2015
26199091ABCG2 Transporter Expression Impacts Group 3 Medulloblastoma Response to Chemotherapy.Cancer Res2015
26091048Dicer Is Required for Normal Cerebellar Development and to Restrain Medulloblastoma Formation.PLoS One2015
  • 1 - 50 of 67

Recommended Authors

Laure Bihannic
St. Jude Children's Research Hospital
Career Start Year 2013
Number of shared co-authors 34
Sachin A Kumar
University of Toronto
Career Start Year 2012
Number of shared co-authors 56
Noriyuki Kijima
Osaka University Graduate School of Medicine
Career Start Year 2011
Number of shared co-authors 56
David R Raleigh
University of California san francisco
Career Start Year 2010
Number of shared co-authors 8
Jessica D Schulte
University of California
Career Start Year 2010
Number of shared co-authors 0
Katie B Grausam
Board of Governor's Regenerative Medicine Institute, Cedars-Sinai Medical Center .
Career Start Year 2008
Number of shared co-authors 8
Matthew D Wood
Oregon Health & Science University
Career Start Year 2007
Number of shared co-authors 11
Chitra Venugopal
McMaster Stem Cell and Cancer Research Institute
Career Start Year 2006
Number of shared co-authors 16
Xi Huang
The Hospital for Sick Children
Career Start Year 2005
Number of shared co-authors 62
Muh-Lii Liang
MacKay Memorial Hospital
Career Start Year 2003
Number of shared co-authors 15
Daniel Martinez
Perelman School of Medicine at the University of Pennsylvania
Career Start Year 2002
Number of shared co-authors 12
Kyeung Min Joo
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Career Start Year 2002
Number of shared co-authors 1
Massimo Squatrito
Seve Ballesteros Foundation Brain Tumor group
Career Start Year 2002
Number of shared co-authors 4
Sheila K Singh
McMaster University
Career Start Year 2001
Number of shared co-authors 38
Emmanuelle Huillard
INSERM, CNRS, Institut du Cerveau-Paris Brain Institute (ICM), Sorbonne Universite
Career Start Year 2000
Number of shared co-authors 4
Naoki Shinojima
Kumamoto University Hospital
Career Start Year 2000
Number of shared co-authors 1
Brian R Rood
Brain Tumor Institute, Children's National Hospital
Career Start Year 1998
Number of shared co-authors 37
Ian D Clarke
Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children
Career Start Year 1997
Number of shared co-authors 49
Do-Hyun Nam
Samsung Medical Center, Sungkyunkwan University School
Career Start Year 1996
Number of shared co-authors 13
Michael A Grotzer
University Children's Hospital
Career Start Year 1994
Number of shared co-authors 92
Nadia Dahmane
Weill Cornell Medical College
Career Start Year 1994
Number of shared co-authors 2
Xiao-Nan Li
Northwestern University
Career Start Year 1992
Number of shared co-authors 73
Annie Huang
Arthur and Sonia Labatt Brain Tumor Research Centre, Hospital for Sick Children
Career Start Year 1990
Number of shared co-authors 94
Howard Colman
Huntsman Cancer Institute, University of Utah
Career Start Year 1990
Number of shared co-authors 40
Ho-Keung Ng
Chinese University of Hong Kong
Career Start Year 1987
Number of shared co-authors 86
Ryo Nishikawa
Saitama Medical University International Medical Center
Career Start Year 1986
Number of shared co-authors 15
Kenneth Aldape
National Cancer Institute
Career Start Year 1985
Number of shared co-authors 96
Gaetano Finocchiaro
IRCCS San Raffaele Scientific Institute
Career Start Year 1983
Number of shared co-authors 58
David H Rowitch
Wellcome Trust-Medical Research Council Stem Cell Institute and.
Career Start Year 1983
Number of shared co-authors 25
Gregory N Fuller
MD Anderson Cancer Center
Career Start Year 1978
Number of shared co-authors 25

Collaborators

Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 17
Martine F Roussel
St. Jude Children's Research Hospital
Co-authored papers 14
Marcel Kool
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 12
Andrey Korshunov
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 11
David T W Jones
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 11
Richard J Gilbertson
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 9
Peter Lichter
German Cancer Research Center (DKFZ)
Co-authored papers 8
Paul A Northcott
St Jude Children's Research Hospital
Co-authored papers 7
Kristian W Pajtler
Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University
Co-authored papers 6
Konstantin Okonechnikov
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 5
David W Ellison
St. Jude Children's Research Hospital
Co-authored papers 5
Laura Sieber
Preclinical Pediatric Oncology, Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 5
Felix Sahm
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 5
Giles W Robinson
St. Jude Children's Research Hospital
Co-authored papers 4
Guido Reifenberger
Heinrich Heine University
Co-authored papers 4
Lukas Chavez
University of California San Diego
Co-authored papers 4
Michael D Taylor
The Hospital for Sick Children
Co-authored papers 4
Stephen C Mack
St Jude Children's Research Hospital
Co-authored papers 4
Olivier Ayrault
Institut Curie, PSL Research University, CNRS UMR, INSERM
Co-authored papers 4
Andreas von Deimling
Co-authored papers 4
Amar Gajjar
St. Jude Children's Research Hospital
Co-authored papers 3
Frederique Zindy
St. Jude Children's Research Hospital
Co-authored papers 3
Marina Ryzhova
N.N. Burdenko Neurosurgical Institute
Co-authored papers 3
Jan O Korbel
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers 3
Jerold E Rehg
St. Jude Children's Research Hospital
Co-authored papers 3
Vijay Ramaswamy
Hospital for Sick Children
Co-authored papers 3
Robert Kupp
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 3
Frank B Furnari
University of California San Diego
Co-authored papers 3
Marc Remke
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 3
Marc Zapatka
Co-authored papers 3
Release 1.2